(redirected from Autologous Chondrocyte Implantation)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for implantation

(embryology) the organic process whereby a fertilized egg becomes implanted in the lining of the uterus of placental mammals

the act of planting or setting in the ground

a surgical procedure that places something in the human body

References in periodicals archive ?
Of those four segments, the markets for autologous chondrocyte implantations and bone morphogenetic proteins have become monopolies.
Autologous chondrocyte implantation of the ankle: a 2- to 5-year follow-up.
At 3-5 years after surgery, patients who underwent autologous chondrocyte implantation (ACI) had significantly fewer symptoms, greater functional improvement, and a lower treatment failure rate than subjects who underwent marrow stimulation techniques, Dr.
Autologous Chondrocyte Implantation in the hip: case report and technique.
Autologous chondrocyte implantation was first described, in 1994, by Brittberg and colleagues.
This new procedure is intended to replace time-consuming autologous chondrocyte implantation (ACI).
TORONTO -- Autologous chondrocyte implantation appears to be the clear treatment of choice for osreochondritis dissecans, Dr.
The report also covers autologous chondrocyte implantation and hyaluronic acid viscosupplementation therapies.
Autologous chondrocyte implantation is indicated in the management of focal chondral defects in the knee.
The product is used in combination with Autologous Chondrocyte Implantation (ACI), a surgical procedure to treat cartilage defects by using the patient's own cells.
These techniques include osteochondral autograft transfer, autologous chondrocyte implantation, and osteochondral allograft transplantation.
This will boost the autologous chondrocyte implantation (ACI) market toward the end of the forecast period because all existing products in the market, as well as those entering it, are now required to undergo a centralized marketing authorization procedure, ensuring not only safe and high-quality products throughout Europe, but also opening up markets that previously had strict legislation concerning tissue-engineered products.
The European orthopedic biomaterials market includes bone graft substitutes (BGS), hyaluronic acid (HA) viscosupplementation, bone morphogenetic protein (BMP) growth factor therapy and autologous chondrocyte implantation (ACI).
Sub-Segments Included: Autograft Standard Allograft Demineralized Bone Matrix Synthetic Bone Graft Xenograft BMP-2 BMP-7 Human Embryonic Stem Cells Mesengchymal Stem Cells Lumbar Spine Stem Cells Cervical Spine Stem Cells Platelet-Rich Plasma Orthopedic Concentrated Bone Marrow Aspirate Single-Injection Three-Injection Cycle Three/Five-Injection Cycle BTB Graft Soft Tissue Grafts Ligament and Tendon Synthetic Graft Osteochondral Allograft Autologous Chondrocyte Implantation Meniscal Allograft Tansplantation ALIF Machined Bone Allograft PLIF Machined Bone Allograft TLIF Machined Bone Allograft CIF Machined Bone Allograft
Full browser ?